Bespoke Extracts, Inc.

BSPK

US08634Q2084

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 19:57:56 22/05/2024 BST			5-day change	1st Jan Change
0.13 ^USD	+57.43%		+30.00%	+266.20%

04-18	Bespoke Extracts, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
02-16	Bespoke Extracts, Inc. announced that it has received $0.1 million in funding	CI

Bespoke Extracts, Inc. Announces Its Plan to Reintroduce Umf® (Unique Manuka Factor) 15+ Rated Manuka Honey-Infused Cbd Formulations

January 13, 2021 at 02:04 pm

Bespoke Extracts, Inc. announced its plan to reintroduce UMF® (Unique Manuka Factor) 15+ rated Manuka Honey-infused CBD formulations to be available for purchase on www.bespokeextracts.com beginning in February 2021.

Latest news about Bespoke Extracts, Inc.

Bespoke Extracts, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-18	CI
Bespoke Extracts, Inc. announced that it has received $0.1 million in funding	02-15	CI
Bespoke Extracts, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	01-16	CI
Bespoke Extracts, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	28/09/23	CI
Bespoke Extracts, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	14/07/23	CI
Bespoke Extracts, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	27/04/23	CI
Bespoke Extracts, Inc. Auditor Raises 'Going Concern' Doubt	26/04/23	CI
Bespoke Extracts, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	21/11/22	CI
Bespoke Extracts, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	19/08/22	CI
Bespoke Extracts, Inc. entered into a definitive agreement to acquire the Assets of Osiris, LLC for $1.58 million.	11/08/22	CI
Bespoke Extracts, Inc. announced that it has received $0.0922 million in funding from Infinity Management LLC and other investors	29/06/22	CI
Bespoke Extracts, Inc. announced that it expects to receive $0.0922 million in funding from Infinity Management LLC and other investors	22/05/22	CI
Bespoke Extracts, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22	CI
Bespoke Extracts, Inc. Reports Earnings Results for the Four Months Ended December 31, 2021	24/03/22	CI
Bespoke Extracts, Inc. Reports Earnings Results for the Four Months Ended December 31, 2021	24/03/22	CI
Bespoke Extracts, Inc. Changes Fiscal Year from August 31 to December 31	04/02/22	CI
Bespoke Extracts, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2021	19/01/22	CI
Bespoke Extracts, Inc. announced that it has received $0.25 million in funding	30/12/21	CI
Bespoke Extracts, Inc. announced that it expects to receive $0.25 million in funding	26/12/21	CI
Bespoke Extracts, Inc. Announces Appointment of Hunter Garth as President	15/12/21	CI
Bespoke Extracts, Inc. Reports Earnings Results for the Full Year Ended August 31, 2021	13/12/21	CI
Bespoke Extracts, Inc. Auditor Raises 'Going Concern' Doubt	12/12/21	CI
Bespoke Extracts, Inc. agreed to acquire Assets of Wonderleaf, LLC from Wonderleaf, LLC for $0.23 million.	01/12/21	CI
Infinity Management LLC completed the acquisition of 20.1% stake in Bespoke Extracts, Inc. from Danil Pollack.	18/11/21	CI
Bespoke Extracts, Inc. Announces Management Changes	29/10/21	CI

Chart Bespoke Extracts, Inc.

Duration

Period

More charts

Company Profile

Bespoke Extracts, Inc. operates in the regulated cannabis markets in the United States. The Company owns, manufactures, and distributes a portfolio of cannabis consumer packaged goods brands including Fresh Joints, Box-O-Joints, and Wee Joints, to licensed marijuana dispensaries across Colorado. Through its wholly owned subsidiary, Bespoke Extracts Colorado, LLC, the Company operates Wonderleaf LLC (WonderLeaf), a marijuana-infused products production facility in Aurora, Colorado. The Company manufactures a range of premium pre-rolled joints. The Company has offered cannabis products focusing on two primary categories: Branded Products and Processing Business. It plans to pursue production of brands of pre-rolled joints and other processed marijuana products under newly created brand names. It also plans to explore licensing existing brands from other states and producing them in Colorado.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BESPOKE EXTRACTS, INC.	+266.20%	1.32M
ELI LILLY AND COMPANY	+38.51%	727B
NOVO NORDISK A/S	+33.05%	599B
JOHNSON & JOHNSON	-6.23%	354B
MERCK & CO., INC.	+18.78%	328B
ABBVIE INC.	+1.35%	277B
ASTRAZENECA PLC	+16.00%	243B
NOVARTIS AG	+8.09%	205B
ROCHE HOLDING AG	-5.77%	203B
AMGEN INC.	+6.19%	164B